SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Teva Women's Health, Inc. Announces for the First Time Results of Pivotal Phase III Study of Quartette™ (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) at the 68th Annual Meeting of American Society for Reproductive Medicine